Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects

NCT00952913 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Bosutinib
DRUG: Bosutinib
DRUG: Lansoprazole

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer